Three Chinese drugmakers are under investigation for crimes including using counterfeit medicines… The China Food and Drug Administration said it was investigating Hebei Yongfeng Yaoye, a subsidiary of Hong Kong-listed CSPC Pharmaceutical Group, as well as Gansu Dadeli Pharmaceutical and Guizhou Shouxian Pharmaceutical.